<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIM: In guidelines 2010 for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> from the Japanese Society for <z:e sem="disease" ids="C0007102" disease_type="Neoplastic Process" abbrv="">Cancer of the Colon</z:e> and Rectum (JSCCR), the criteria for identifying curable T1 colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> after endoscopic resection were well/moderately differentiated or papillary histologic grade, no vascular invasion, submucosal invasion depth less than 1000 µm and budding grade 1 (low grade) </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to expand these criteria </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A total of 499 T1 colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, resected endoscopically or surgically, were analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>Relationships between clinicopathologic findings and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> were evaluated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was found in 41 (8.22%) of the 499 cases </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was significantly higher in lesions featuring poorly differentiated/mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, submucosal invasion ≥ 1800 µm, vascular invasion, and high-grade <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> budding than in other lesions </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate logistic regression analysis showed <z:hpo ids='HP_0000001'>all</z:hpo> of these variables to be independent risk factors for lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>When cases that met three of the JSCCR 2010 criteria (i.e. <z:hpo ids='HP_0000001'>all</z:hpo> but invasion &lt; 1000 µm) were considered together, the incidence of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was only 1.2% (3/249, 95% confidence interval: 0.25-3.48%), and there were no cases of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> without submucosal invasion to a depth of ≥ 1800 µm </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Even in cases of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> with deep submucosal invasion, the risk of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is minimal under certain conditions </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, even for such cases, endoscopic incisional biopsy can be suitable if complete en bloc resection is achieved </plain></SENT>
</text></document>